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Abstract
Th e almost universal administration of childhood immunisations has been associated with logarithmic 
drops in the incidence of a number of diseases in the United States and worldwide. In the United 
States, mandatory school immunisation laws have in particular been instrumental in achieving the 
high levels of coverage needed to sustain herd immunity. However, concerns about vaccine safety led 
to the passing of the National Childhood Vaccine Injury Act of 1986, which uses a no-fault system 
compensation system for people found to be injured by certain vaccines. Th e measles vaccine is highly 
eff ective, and outbreaks of measles are usually the consequence of failure to vaccinate. A high-profi le 
outbreak of measles at a southern California amusement park in 2014 led the state of California 
to further restrict the ability of children to attend school if they are not immunized because of their 
family’s beliefs. Immunisation requirements are but one of many legal mandates designed for public 
health protection, from mandatory fl uoridation of drinking water to quarantine and isolation for 
communicable diseases. We conclude that school immunisation requirements help governments fulfi l 
their duty to protect and promote public health.
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1. INTRODUCTION2
On a global scale, the incidence and associated mortality of infectious diseases has fallen 
steadily since the mid-1950s (Hinman, 1989). Th is decline has been particularly noted 
for vaccine-preventable diseases, including diphtheria, pertussis, tetanus, poliomyelitis, 
measles, mumps and rubella (CDC, 1999). In more recent times, immunisation helped 
1 Th e authors have no confl icts of interest. Portions of this paper were presented at the Price of Health 
conference on August 13, 2016, in Dubrovnik, Croatia.
2 We thank Sarah Royce, M.D., M.P.H., Chief, Immunizations Branch, California Department of Public 
Health, and Yvonne Maldonado, M.D., Professor of Pediatrics and Chief, Division of Pediatric Infectious 
Diseases, Department of Pediatrics, Stanford University Medical Center, for their advice and sharing data.
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eradicate smallpox by 1978 (Fenner, 1982), eliminated endemic polio, rubella and me-
asles in the Americas (PAHO, 2015, 2016), and virtually eliminated invasive Haemop-
hilus infl uenzae type b infections in high-income countries (Peltola, 2000).
Th ese declines in mortality are especially evident in children. For instance, in a parti-
cularly careful analysis undertaken in the Netherlands, the years of life lost before 20 
years of age fell steadily from the cohort of children born in 1903 to the cohort born 
in 1992 (van Wijhe et al., 2016). Mortality declined most precipitously for diphtheria 
and pertussis, and the authors have calculated that there were 3,000 fewer deaths and 
38,000 fewer years of life lost before age 20 from diphtheria, and 6,000 fewer deaths 
and 103,000 fewer years of life lost before age 20 from pertussis after the introduction 
of mass vaccination programmes for these agents in 1953 and 1954 respectively (van 
Wijhe et al., 2016). Equally impressive was the rapid decline in Haemophilus infl uenzae 
type b. In the United States of America, for example, the incidence of invasive disease 
declined from a high of 25 cases per 100,000 children under 5 years of age in 1984 to 
almost 0 in 1997 (Adams et al., 1993; CDC, 1998). Th is was due to the introduction 
of a single-dose polysaccharide vaccine in 1986 and then a multi-dose conjugate vaccine 
series in 1990. It has been estimated that mass vaccination against Haemophilus infl uen-
zae type b has saved 13,700 lives in the United States from 1994 to 2013 (CDC, 2014).
Despite the clear public health success of mass childhood immunisations, such pro-
grammes are not without their critics. In this paper we review the United States expe-
rience with mandatory childhood immunisations and one state’s (California) experience 
with these programmes.
2. IMMUNISATION REQUIREMENTS FOR SCHOOL ENTRY, 
UNITED STATES
In the United States, public health law is primarily the province of state governments. 
Each state enacts its own set of public health laws, which can diff er from state to state. 
Federal public health law is largely restricted to issues of communicable disease control 
at national borders and regulation of interstate commerce, for instance, of drugs and 
diagnostic devices (Gostin and Wiley, 2016). Th e federal government provides funding 
and technical assistance to states through agencies such as the Centers for Disease Con-
trol and Prevention in order to assist them in promoting public health in general and to 
control communicable diseases of public health signifi cance in particular.
Th e responsibility of the states for public health derives from their duty to protect their 
citizens and have their origin in their police powers (Gostin and Wiley, 2016). For com-
municable disease control, the states have the power to limit individual liberty in order 
to protect public health through interventions such as quarantine and isolation. Immu-
nisation requirements are an extension of these duties and powers. But, as with many 
laws, there is a balance between protecting public health while preserving individual li-
berties and commerce to the greatest extent possible. Overriding all these considerations 
is the medical tenet of doing no harm (Gostin and Gostin, 2009).
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Th ere is a long history of requiring citizens to be immunised in the United States (Cole, 
and Swendiman, 2014). Th e fi rst school vaccination requirements were enacted in 1850 
in Massachusetts to prevent smallpox. As early as 1905, the United States Supreme Co-
urt in Jacobsen versus Massachusetts rejected the argument that an individual could refuse 
to be vaccinated for smallpox because he knew best how to care for his own body (Par-
met et al., 2005; Duff y, 1978). Th is landmark decision and others that followed allowed 
states to enact laws and regulations that required children to be immunised for certain 
communicable disease prior to entering school, and by 1980, all states had such requi-
rements (Hinman et al., 2002). At the same time, almost all states allowed exemptions 
for medical contraindications or for philosophical or religious reasons. Figure 1 shows 
which states allowed for religious exemptions and religious or philosophical exemptions 
in 2015 (NCSL, 2016). Only two states at that time, Mississippi and West Virginia, did 
not allow these exemptions.
Figure 1. Religious and philosophical exemptions to school vaccination laws by state, Uni-
ted States of America, 2015 (Hinman et al., 2002).
Th e United States has long recognised that there is a low background rate of severe 
adverse events following childhood immunisation that can lead to permanent harm. 
Along with individual rights, issues of avoiding potential harm are at the heart of the 
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anti-vaccination movement (College of Physicians of Philadelphia, 2017). To remedy 
injuries that might have resulted from mandatory immunisation, the United States ena-
cted the National Vaccine Compensation Act in 1986 (Smith, 1988). Th e Act created 
a no-fault alternative system to the traditional tort system for immunisation-associa-
ted injuries. As a result, it was anticipated that the Act would help retain vaccine ma-
nufacturers on the market, assure an adequate supply of vaccines, and stabilise vaccine 
prices. Compensation is funded by a $0.75 excise tax on each of the covered vaccines 
(HRSA, 2017). Th e claims process has fi ve steps (see Box 1). 
When pre-specifi ed conditions, such as anaphylaxis, occur within defi ned time periods 
after immunisation, it is presumed that the vaccine was the cause unless proven otherwi-
se, and the aff ected individual is eligible for compensation. Persons with injuries that are 
not pre-specifi ed are still eligible for compensation if they can prove that immunisation 
was the cause. Th ere were 3,521 claims fi led from 2006 to 2014, against a background 
of 2.5 billion doses administered (one claim for every 710,000 vaccines administered). 
Of these 3,521 claims, 2,248 (64%) received compensation. Since the programme be-
gan in 1988, the total amount awarded has been $3.4 billion for 4,804 compensated 
claims ($70,000 per claim).
Immunisation against up to nine pathogens is currently required for entering Califor-
nia schools, whether they be public or private, or to pre-schools and child care centres. 
Immunisations required for kindergarten include poliomyelitis (4 doses), diphtheria 
and tetanus toxoids and pertussis vaccine (5 doses, as DTP, DTaP or DT), hepatitis B 
(3 doses), measles, rubella and mumps (2 doses of measles-containing vaccine), and va-
ricella (1 dose) (Smith, 1988). DTP can be administered as whole cell pertussis vaccine 
(P), which is no longer available in the United States, or acellular pertussis vaccine (aP). 
Children who have had adverse events after DTP or DTaP may complete their require-
ments with diphtheria and tetanus toxoids (DT). 
Additionally, children entering or advancing into seventh grade are required to have 
an additional dose of reduced diphtheria toxoid, tetanus toxoids and acellular pertussis 
vaccine (Dtap). Prior to 2016, California law allowed for two types of exemptions to 
these required immunisations: those based on medical reasons, such as immunosuppre-
ssion, which could be either permanent or temporary, and those due to personal beliefs, 
whether religious or otherwise. Over the last 15 years, the proportion of children en-
tering kindergarten in California who have had all their required immunisations has 
fallen from almost 93% to less than 91%. Th is decline was much more pronounced 
for children entering private schools, where coverage fell from 90% to 86% (Figure 2). 
In the autumn of 2015 of the 551,123 children entering kindergarten in California, 
511,708 (92.9%) were reported as having received all their required immunisations, 
24,424 (4.4%) had been admitted conditionally, meaning that they were still comple-
ting their requirements after past delays or had temporary medical exemptions, and 
974 (0.2%) were overdue for their fi nal immunisation (HRSA, 2017). An additional 
931 (0.2%) children had permanent medical exemptions, and 13,086 (2.4%) claimed 
personal belief exemptions.
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3. THE PROBLEM WITH MEASLES
Measles is possibly the most infectious of childhood diseases. Spread in respiratory se-
cretions, the measles virus can cause severe multiorgan system disease (Holzmann et 
al., 2016). Young children who are exposed after the transplacental maternal antibody 
wanes are at particularly high risk of life-threatening sequelae, such as pneumonia and 
diarrhoea. Th us, infants and young children need to be immunised as soon as possible 
after maternal antibodies have disappeared; in the United States, the recommended age 
for measles immunisation is typically between 12 and 15 months of age (CDC, 2013).
Th e extreme contagiousness of measles is refl ected in an estimated 92-94% threshold 
herd immunity level necessary to interrupt transmission (Fine and Mulholland, 2008). 
Failures either to achieve or sustain such levels of immunity are the main challenges 
with measles. If parents wait to immunise their children against measles until entering 
school at 5 years of age, the ensuing pool of non-immune children can sustain an epide-
mic transmission. Th is is what happened in California, and indeed throughout the We-
stern Hemisphere, from 1988 to 1990 (Dales et al, 1993). Once widespread transmis-
sion starts, measles spreads not only to unvaccinated people who had not been exposed 
to endemic measles in the years since the measles vaccine was introduced, but also to 
those whose immunisations have failed. Th e measles vaccine is ineff ective in about 5% 
of children immunised in the absence of a maternal antibody. If revaccinated, 95% of 
this 5% will become protected. To close this gap in immunity, in 1989 the US Advisory 
Figure 2. Percentage of California kindergarten enterers with all required immunisations 
by school type, 2000-2001 to 2014-2015.
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Committee on Immunization Practices recommended a second dose of measles vaccine 
(usually given with the mumps and rubella vaccine) for children right before entering 
school (National Vaccine Advisory Committee, 1991).
Measles outbreaks can also occur in populations whose philosophical or religious beliefs 
preclude the attainment of herd immunity. In the wake of well-publicised allegations of 
autism occurring after receiving the MMR vaccine, which was sparked by a case series 
published in 1998 that was eventually retracted, MMR immunisation rates for young 
children in the United Kingdom fell well below the herd immunity threshold (ECDC, 
2008). Even after concerns about the safety of MMR had faded and immunisation rates 
in early childhood had reversed, many older children and adolescents never received re-
medial immunisation (Abertawe Bro Morgannwg University Health Board et al. 2013). 
In 2013 an outbreak in Wales resulted in more than 1,200 cases of measles, with 88 
people hospitalised and 1 fatality (Abertawe Bro Morgannwg University Health Board 
et al. 2013). Most of those affl  icted were younger than 15 years of age, and many were 
unvaccinated, the deferred casualties of the MMR safety scare. In 2014 two outbreaks 
of approximately 400 cases each resulted when travellers to Europe and Asia impor-
ted measles to religious communities in North America with low immunisation rates 
(Naus, et al. 2015; Glover, C. E., 2015). 
Soon thereafter, an outbreak of measles following exposure at a southern California 
amusement park in December 2014 (CDC, 2015b) led to 125 cases in seven states, Ca-
nada and Mexico. Of the 110 cases that occurred in California, at least 60 (55%) were 
unvaccinated; 13 of these were too young to have received the measles vaccine at the 
recommended age, and at least 37 individuals had not been immunised against measles 
because of their families’ personal beliefs.
Th is highly-publicised amusement park outbreak led to the introduction in 2015 of 
California Senate Bill (SB) 277, which proposed to eliminate personal belief exempti-
ons for new entrants into public and private schools and child care centres. Children 
who had received personal belief exemptions before 2016 could remain in school under 
their exemptions until they entered kindergarten (for the case of children in pre-school 
or child care centres) or 7th grade (the grade children enter at 12 years old, for the case 
of children already in elementary school). Children receiving home-based instruction 
and those enrolled in independent study programmes outside of the classroom would 
no longer be subject to school immunisation requirements (California Legislative Infor-
mation, 1995). Advocates for the legislation included parents of a child with leukaemia 
concerned about potential exposures to vaccine-preventable diseases from unimmu-
nised peers. Th e proponents noted that, despite the recent implementation of more 
stringent requirements for personal belief exemptions, in the autumn of 2014 only 
92.6% of children entering kindergarten in California were reported as having had two 
MMRs (California Department of Public Health, 2016b), and 1199 (17%) kindergar-
tens with 10 or more children reported more than 5% of pupils having personal belief 
exemptions to one or more required immunisations (California Department of Public 
Health, 2016a). 
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SB 277 passed through both the California Assembly and the State Senate and was 
signed into law by Governor Jerry Brown on June 30, 2015. As a result, California beca-
me the third state in the United States to disallow personal belief exemptions to entering 
school. In his accompanying message, Governor Brown wrote:
“Th e science is clear that vaccines dramatically protect children against a number of 
infectious and dangerous diseases. While it’s true that no medical intervention is wit-
hout risk, the evidence shows that immunization powerfully benefi ts and protects the 
community.” (Brown, 2015).
Th us, in California at least, mandatory school immunisation requirements codifi ed in 
laws and regulations have been established as a prudent measure designed to protect 
both public health as well as individuals from infectious diseases. 
4. PARALLELS TO OTHER COMMUNICABLE DISEASE CONTROL 
PROGRAMMES
In addition to childhood immunisation programmes, public health law also allows for 
a number of other proscriptive activities to protect public health and control the spread 
of both communicable and at least a few non-communicable diseases. Th ey generally 
fall into three groups – activities that support acquisition of data for public health and 
disease control eff orts, activities that involve mass administration of drugs, and activities 
that directly limit individual liberties in order to protect public health.
Disease reporting and surveillance are long-standing public health activities. Th ey are 
needed to assist public health agencies in identifying individual cases of disease (for in-
stance, individual cases of measles) as well as to understand the epidemiology of a dise-
ase and the on-going patterns of disease transmission (Declich and Carter, 1994). Case 
reporting for individual cases of HIV was particularly controversial when there were few 
therapeutic options and prevention was limited to counselling and condom provision 
(Bayer and Fairchild, 2002). Interestingly, this rapidly changed with the widespread 
availability of antiretroviral drugs (UNAIDS, 2014), changes in antiretroviral treatment 
guidelines to recommend treatment for everyone with HIV (WHO, 2015b), and the 
discovery that antiretroviral therapy can virtually eliminate further sexual transmission 
of HIV (Rutherford and Anglemyer, 2016). More recently data from case reporting has 
become the cornerstone of monitoring and evaluating national and worldwide progress 
to elimination of HIV (WHO, 2015a).
A second group of mandatory public health activities is mass screening, treatment or 
preventive supplementation, the latter including the addition of fl uoride to drinking 
water (Iheozor-Ejiofor et al., 2015), iodide to salt or vitamins to cereal grains (Rai-
tiainen et al., 2016); a prominent example is the decision to supplement cereal grains 
consumed by pregnant women with folic acid to prevent neural tube defects in foetuses 
(Ray et al., 2002). Mass drug administration may also be done at the individual level, 
such as administration of topical antibiotics to all newborns to presumptively treat go-
nococcal ophthalmia and parenteral vitamin K to prevent neonatal haemorrhage (Zi-
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pursky, 1999). In tropical countries where malaria is endemic all pregnant women are 
treated presumptively in the third trimester with antimalarial drugs to prevent the con-
genital transmission of malaria (WHO and Global Malaria Programme, 2012). Mass 
screening programmes focus on identifying newborns with certain metabolic diseases 
that can be ameliorated if treated very early in life, such as congenital hypothyroidism 
and phenylkentonuria (Green et al., 2006). In all these cases the state mandated diagno-
stics, preventive measures and therapeutics, either directly through law or by defi ning 
the standard of care, to protect unborn and newborn children.
Public health laws permitting isolation and quarantine control the spread of commu-
nicable diseases at the cost of restricting individual liberties. Isolation refers to limiting 
the movement of a person with a communicable disease during the infectious period 
of that disease in order to prevent spreading of the disease. Quarantine, on the other 
hand, refers to limiting the movement of a person who has been exposed to (and may 
be infected with) a communicable disease during the potential incubation period of the 
disease. Quarantine and isolation were widely and eff ectively used to limit transmission 
and protect public health during the severe acute respiratory disease (SARS) outbreak 
in China in 2003 (Bondy et al., 2009) and in the recent Ebola virus outbreak in West 
Africa (CDC, 2015a). 
5. CONCLUSIONS
In the United States of America there is a substantial corpus of state and federal law 
designed to protect public health from the spread of communicable diseases. Here we 
have reviewed mandatory school immunisation laws in California and how they have 
changed over time. Th ey are, however, but one example of how the duties of states to 
protect public health are translated into interventions.
In order to limit the transmission of vaccine-preventable diseases, mandatory school 
immunisation laws must support the attainment and maintenance of herd immunity. 
Society has a vested interest in preventing the transmission of these diseases and the 
morbidity and mortality they cause. While waning immunity and vaccine failure do oc-
cur, epidemic disease transmission far too often is the result of failure to vaccinate rather 
than vaccine failure. In an ideal world, all infants and young children would be fully and 
promptly immunised without intervention from the state. Until that day dawns, school 
immunisation laws have proven to be an eff ective way to support vaccine coverage goals 
and to protect public health.
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Box 1. How the National Vaccine Injury Compensation program works (College of Physi-
cians of Philadelphia, 2017).
1. An individual fi les a petition with the U.S. Court of Federal Claims.
2. Th e U.S. Department of Health and Human Services’ (DHHS) medical staff  
reviews the petition, determines if it meets the medical criteria for compensa-
tion and makes a preliminary recommendation.
3. Th e U.S. Department of Justice develops a report that includes the medical 
recommendation and legal analysis and submits it to the Court.
4. Th e report is presented to a court-appointed special master, who decides whet-
her the petitioner should be compensated, often after holding a hearing in 
which both parties can present evidence. If compensation is awarded, the spe-
cial master determines the amount and type of compensation.
5. Th e Court orders DHHS to award compensation. Even if the petition is di-
smissed, if certain requirements are met, the Court may order DHHS to pay 
attorneys’ fees and costs. 
Note: Th e special master’s decision may be appealed and petitioners who reject the 
decision of the court may fi le a claim in civil court against the vaccine company 
and/or the health care provider who administered the vaccine.
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RATOVI CJEPIVA:
ŠTO MOŽEMO NAUČITI IZ KALIFORNIJSKOG ISKUSTVA S 
OBVEZNIM CIJEPLJENJEM ŠKOLSKE DJECE?
George W. Rutherford i Robert Schechter
Sažetak
Gotovo univerzalna imunizacija djece povezana je s logaritamskim opadanjem broja zaraza kako u Sje-
dinjenim Državama tako i svijetu. U Sjedinjenim Državama, zakon o obveznom cijepljenju školske djece 
pokazao se posebno korisnim za postizanje visokog stupnja zaštite potrebne za održavanje imunosti zajed-
nice. Međutim, zabrinutosti oko sigurnosti cjepiva dovele su do donošenja National Childhood Vaccine 
Injury Act (Nacionalni zakon o štetnosti dječjeg cjepiva) iz 1986., prema kojem se kroz „no-fault sustav“ 
(bez obzira tko je kriv) kompenziraju oštećeni određenim cjepivima. Cjepivo protiv ospica iznimno je učin-
kovito, a pojave ospica najčešće su povezane s neprimanjem cjepiva. Zbog poznatog slučaja pojave ospica 
u kalifornijskom zabavnom parku 2014., savezna država Kalifornija dodatno je ograničila mogućnost 
pohađanja škole djece koja nisu cijepljena zbog obiteljskih uvjerenja. Obvezno cijepljenje predstavlja samo 
jednu od odredbi kojima je cilj zaštita javnog zdravlja, a ,eđu kojima su i obvezna fl uoridacija pitke vode 
i karantena i izolacija zbog prenosivih bolesti. Zaključujemo da obvezno cijepljenje školske djece pomaže 
vladama u ispunjenju njihove dužnosti u zaštiti i unaprjeđenju javnog zdravstva. 
Ključne riječi: cijepljenje, zakon o javnom zdravstvu, Kalifornija, hripavac, ospice
IMPFKÄMPFE: WAS KÖNNEN WIR AUS DER KALIFORNISCHEN 
ERFAHRUNG MIT DER PFLICHTIMPFUNG DER SCHULKINDER 
LERNEN?
George W. Rutherford und Robert Schechter
Zusammenfassung
Eine fast universelle Immunisierung der Kinder ist, sowie in den USA als auch in der übrigen Welt, mit 
einer logarithmischen Abnahme der Ansteckungsfälle verbunden. In den USA hat sich das Gesetz über die 
Pfl ichtimpfung von Schulkindern als besonders nützlich zum Erreichen einer hohen Stufe des für Erhal-
ten der Immunität der Gemeinschaft nötigen Schutzes erwiesen. Allerdings haben die Bedenken über die 
Impfsicherheit zum Erlassen des Nationalen Kindheits-Impfstoff -Verletzungsgesetz aus dem Jahr 1986 (Na-
tional Childhood Vaccine Injury Act) geführt, wonach durch ein „No-Fault-System“ (ungeachtet dessen, 
wer die Schuld trägt) die durch bestimmte Impfstoff e Betroff enen entschädigt werden. Der Masernimpfstoff  
ist außerordentlich effi  zient und die Masernfälle sind meistens mit der Nichtimpfung verbunden. Wegen 
des bekannten Falls des Masernausbruchs im kalifornischen Vergnügungspark 2014 hat der Bundesstaat 
Kalifornien zusätzlich den Schulbesuch von Kindern beschränkt, die aus Familienüberzeugung nicht ge-
impft wurden. Die Pfl ichtimpfung ist nur eine von Bestimmungen, deren Ziel der Schutz der öff entlichen 
Gesundheit ist, dazu gehören noch die obligatorische Trinkwasserfl uoridierung, Quarantäne und und Iso-
lation wegen übertragbaren Krankheiten. Wir kommen zum Schluß, dass die Pfl ichtimpfung von Schul-
kindern den Regierungen hilft, ihre Pfl ichten im Rahmen des Schutzes und der Förderung der öff entlichen 
Gesundheit zu erfüllen.
Schlüsselwörter: Impfung, Gesetz über den öff entlichen Gesundheitsdienst, Kalifornien, Keuchhusten, 
Masern
